Company intelligence
CASPDx
Developing Diagnostic Markers for High Incidence Cancers Utilising Inflammatory Signatures
Medical and Diagnostic Laboratories
Dublin, IE
2 employees
1 public signals
About CASPDx
CASPDx aims to disrupt cancer screening with scalable, accurate, and cost-effective biomarkers. Targeting high-incidence cancers with unmet needs, we validate inflammatory signatures to revolutionize early diagnosis and patient outcomes.
Verified activity
Signals from CASPDx
1 published signal